Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.
about
HIV and tuberculosis--science and implementation to turn the tide and reduce deathsHarnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosisReview: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaThe START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomiA 20-year retrospective cohort study of TB infection among the Hill-tribe HIV/AIDS populations, ThailandThe prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem studyCost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaThe impact of HIV, an antiretroviral programme and tuberculosis on mortality in South African platinum miners, 1992-2010Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developmentsAntiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township.Changing concepts of "latent tuberculosis infection" in patients living with HIV infection.Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township.Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.A combination strategy for enhancing linkage to and retention in HIV care among adults newly diagnosed with HIV in Mozambique: study protocol for a site-randomized implementation science study.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as preventionIncidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi.Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational researchPancreatic tuberculosis with acquired immunodeficiency syndrome: a case report and systematic review.Antiretroviral outcomes in South African prisoners: a retrospective cohort analysisThe Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trialPerspectives on introduction and implementation of new point-of-care diagnostic testsThe cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.Antiretroviral therapy in prevention of HIV and TB: update on current research effortsCosting human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African settingAntiretroviral treatment as prevention: impact of the 'test and treat' strategy on the tuberculosis epidemic.Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, EthiopiaTuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.Impact of WHO 2010 Guidelines on Antiretroviral Therapy Initiation among Patients with HIV-Associated Tuberculosis in Clinics with and without Onsite HIV Services in the Democratic Republic of Congo
P2860
Q26824501-2AF44684-9CA6-474E-A293-9AF49B6EBC4DQ26828443-53F5F28C-589E-41AB-8528-9DF2B837ED6EQ27022927-BD3670DB-BC41-4A2C-88FD-5E90D61FB3A7Q27303476-B7B8C664-D475-4A5B-8535-444D4507EFDDQ28070006-7696CA8C-42C6-43B0-A990-4CD89AB44452Q28474623-CA6D3C78-2DFB-4738-9500-4E8BE781245CQ28554655-4DB74F2B-A8C0-41CB-84EE-D6BD932C2B41Q28728096-93F37BB0-6E15-4E67-9272-5C5D1116880AQ33700455-265D2E38-9AA4-4CA4-97A9-C7B025DAD26FQ33745099-6EA2CD99-EA35-42CA-9FC3-429434F5470DQ33754177-64F3DF8B-F1CA-4B8F-B476-680A5A929163Q33795967-354A99D8-08D3-420F-A647-0D45670B0C43Q33952538-9578DD18-6B39-400D-8E68-A99C8B018DF2Q34034880-34E5195B-B696-4C14-B2AC-237769E538A4Q34170017-DD466D24-073E-44AB-BEA7-324D7177032EQ34222186-81BA45E1-BA29-4FEB-8E85-96998B9D72D5Q34268952-A48C3B71-4C24-4D79-8F47-31E84F0AD254Q34344980-4464556F-CB49-4922-BDF5-3F6708910A0EQ34410468-142A0AF8-F450-4B07-8BFE-0198E6D337B2Q34455442-E4B2DC7C-E43C-4693-9877-2A81E6E2D820Q34499835-0C099026-846C-473B-AEA4-BB2F8B757B83Q34519553-2C5B2044-7E79-4302-814E-391D563509FEQ34563388-09C6C254-D2F1-4D7C-BE4D-8FCB6AB09E90Q34589601-E0C97B51-2068-4A3C-AB83-613DF874AB12Q35098738-2DCCC89B-334E-477C-AF74-B7A3E5E7B9A5Q35336481-5E87DAD3-5BA0-42BB-8E5A-CF678659E875Q35357639-4F58344C-1A3B-4C66-93EC-0EDD4C59DD2EQ35761729-E89F2FBF-6663-4571-B25B-261C4222FA97Q35845607-42DCF737-EB66-44F8-AABD-2773ECA5CD85Q35864187-BCF48FE5-E334-4850-8874-541BB4B13718Q35907400-1225A544-5FEB-4745-A7D8-EDCDF2BFF0AAQ36454787-577EAA75-FF12-4B62-87C7-978DB24815E9Q36493044-BABADD4F-E0E0-43CB-ACAE-42F6D78EC0FFQ36493052-A8EE2513-08B6-4F18-B279-FE84EF44CCA9Q36509003-B6466F31-1614-4EE4-9555-836576DE0391Q36825990-11630816-6F83-405F-8C7C-4C08F1BE43E5Q37029920-FB90CC3A-5B04-438F-A281-0161BFC81B6AQ37033512-4A1D37E2-EF25-4C34-806B-DC49AD34F99FQ37168588-F73D6046-BDA9-4813-B967-DCB93A0DCEEDQ37195317-FEAAADFB-594C-44EE-9E61-88DF93AA23BB
P2860
Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antiretroviral therapy for con ...... in resource-limited settings.
@ast
Antiretroviral therapy for con ...... in resource-limited settings.
@en
type
label
Antiretroviral therapy for con ...... in resource-limited settings.
@ast
Antiretroviral therapy for con ...... in resource-limited settings.
@en
prefLabel
Antiretroviral therapy for con ...... in resource-limited settings.
@ast
Antiretroviral therapy for con ...... in resource-limited settings.
@en
P2860
P921
P1476
Antiretroviral therapy for con ...... in resource-limited settings.
@en
P2093
Katharina Kranzer
P2860
P304
685-99, viii
P356
10.1016/J.CCM.2009.08.010
P5008
P577
2009-12-01T00:00:00Z